BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37188611)

  • 21. Validation of a Simple Score to Determine Risk of Early Rejection After Pediatric Heart Transplantation.
    Butts RJ; Savage AJ; Atz AM; Heal EM; Burnette AL; Kavarana MM; Bradley SM; Chowdhury SM
    JACC Heart Fail; 2015 Sep; 3(9):670-6. PubMed ID: 26362445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Airway inflammation and symptoms in children following liver and heart transplantation.
    Redmann AJ; Bucuvalas JC; Wood RE; Chin C; Hart CK
    Clin Transplant; 2017 Jun; 31(6):. PubMed ID: 28316109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maintenance steroid use at 30 days post-transplant and outcomes of pediatric heart transplantation: A propensity matched analysis of the Pediatric Heart Transplant Study database.
    Auerbach SR; Kukreja M; Gilbert D; Bastardi H; Feingold B; Knecht K; Kaufman BD; Brown RN; Miyamoto SD
    J Heart Lung Transplant; 2015 Aug; 34(8):1066-72. PubMed ID: 25980572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric heart transplantation at adult-specialty centers in the United States: A multicenter registry analysis.
    Duong SQ; Yabes JG; Teuteberg JJ; Shellmer DA; Feingold B
    Am J Transplant; 2018 Sep; 18(9):2175-2181. PubMed ID: 29758130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune cell function assay in pediatric heart transplant recipients.
    Wong MS; Boucek R; Kemna M; Rutledge J; Law Y
    Pediatr Transplant; 2014 Aug; 18(5):485-90. PubMed ID: 24930882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early report from the Pediatric Heart Transplant Society on COVID-19 infections in pediatric heart transplant candidates and recipients.
    Conway J; Auerbach SR; Richmond ME; Sharp B; Pahl E; Feingold B; Azeka E; Dryer WJ; Cantor RS; Kirklin JK;
    J Heart Lung Transplant; 2022 Mar; 41(3):327-333. PubMed ID: 34903451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of older donor age and survival after weight-matched pediatric heart transplantation.
    Westbrook TC; Morales DLS; Khan MS; Bryant R; Castleberry C; Chin C; Zafar F
    J Heart Lung Transplant; 2017 May; 36(5):554-558. PubMed ID: 28073609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De novo collapsing glomerulopathy in a pediatric kidney transplant recipient with COVID-19 infection.
    Levenson E; Shepherd TN; Aviles D; Craver R; Ehlayel A; Love GL; Simms K; Straatmann C; Ashoor IF
    Pediatr Transplant; 2021 Jun; 25(4):e14013. PubMed ID: 33773007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance for transplant coronary artery disease in infant, child and adolescent heart transplant recipients: an intravascular ultrasound study.
    Nicolas RT; Kort HW; Balzer DT; Trinkaus K; Dent CL; Hirsch R; Canter CE
    J Heart Lung Transplant; 2006 Aug; 25(8):921-7. PubMed ID: 16890112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular magnetic resonance imaging in asymptomatic acute heart rejection: a case report.
    Urbanowicz T; Kociemba A; Pyda M; Katyńska I; Straburzyńska-Migaj E; Baszyńska-Wachowiak H; Misterski M; Grajek S; Jemielity M
    Ann Transplant; 2014 Sep; 19():447-51. PubMed ID: 25196557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes after ABO-incompatible heart transplantation in adults: A registry study.
    Bergenfeldt H; Andersson B; Bućin D; Stehlik J; Edwards L; Rådegran G; Nilsson J
    J Heart Lung Transplant; 2015 Jul; 34(7):892-8. PubMed ID: 25754241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of gene expression profiling score, cardiac hemodynamics and echocardiographic parameters in asymptomatic, rejection-free pediatric heart transplant recipients.
    Das BB; Chan KC; Winchester RW; Zakrzewski M; Niu J
    Pediatr Transplant; 2020 May; 24(3):e13673. PubMed ID: 32067334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of induction therapy on cytomegalovirus infection and post-transplant outcomes in pediatric heart transplant recipients receiving routine antiviral prophylaxis.
    Zang S; Zhang X; Niu J; Das BB
    Clin Transplant; 2023 Jan; 37(1):e14836. PubMed ID: 36259556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapidly progressive graft vasculopathy in a heart transplant recipient with confirmed SARS-CoV-2 infection.
    MacKay M; Clewis M; Khalife W
    Transpl Infect Dis; 2024 Feb; 26(1):e14225. PubMed ID: 38152037
    [No Abstract]   [Full Text] [Related]  

  • 35. Risk evaluation using gene expression screening to monitor for acute cellular rejection in heart transplant recipients.
    Moayedi Y; Foroutan F; Miller RJH; Fan CS; Posada JGD; Alhussein M; Tremblay-Gravel M; Oro G; Luikart HI; Yee J; Shullo MA; Khush KK; Ross HJ; Teuteberg JJ
    J Heart Lung Transplant; 2019 Jan; 38(1):51-58. PubMed ID: 30352779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics, risks, and outcomes of post-transplant lymphoproliferative disease >3 years after pediatric heart transplant: A multicenter analysis.
    West SC; Friedland-Little JM; Schowengerdt KO; Naftel DC; Pruitt Freeze E; Smith KS; Urschel S; Michaels MG; Kirklin JK; Feingold B
    Clin Transplant; 2019 May; 33(5):e13521. PubMed ID: 30861200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients.
    Singh TP; Faber C; Blume ED; Worley S; Almond CS; Smoot LB; Dillis S; Nasman C; Boyle GJ
    J Heart Lung Transplant; 2010 May; 29(5):517-22. PubMed ID: 20061164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes in recipients of combined heart-kidney transplantation: multiorgan, same-donor transplant study of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing Scientific Registry.
    Narula J; Bennett LE; DiSalvo T; Hosenpud JD; Semigran MJ; Dec GW
    Transplantation; 1997 Mar; 63(6):861-7. PubMed ID: 9089227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry.
    Wever-Pinzon O; Edwards LB; Taylor DO; Kfoury AG; Drakos SG; Selzman CH; Fang JC; Lund LH; Stehlik J
    J Heart Lung Transplant; 2017 Apr; 36(4):407-417. PubMed ID: 27686602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
    Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA
    J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.